跳至主要内容
临床试验/NCT02374944
NCT02374944招募中不适用

A Randomized Clinical Trial Evaluating Fixation Insitu Versus Removal for Midfoot Lisfranc Injuries

University of Calgary3 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2018年1月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
94
试验地点
3
主要终点
SF-36

研究概览

简要总结

This study is a multicenter prospective randomized control trial comparing hardware retention (HR) to removal of hardware (RH).

详细描述

Eligible patients will be randomized to one of two treatment arms: Hardware removal at 6 months or Hardware retention for a minimum of 2 years.

Consenting patients having previously undergone open reduction and internal fixation of Lisfranc injuries with an anatomic reconstruction within 6-8 weeks will be randomized to one of two treatment arms: removal hardware (RH) or hardware retention (HR).

Outcome will be assessed at 6 weeks, 12 weeks, 6 months, 1 year, and 2 years from enrollment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject has Lisfranc injury that was treated within 28 days of injury.
  • Subject must be enrolled in study between 6 and 8 weeks from time of initial fixation operation.
  • The patient must be medically fit for anesthesia
  • Subject is willing and able to provide written informed consent for trial participation
  • Subject is willing and able to comply with the study protocol including return for all follow-up evaluations
  • Subject may have a bony, ligamentous, or combined lisfranc injury
  • Demonstrated instability of the lisfranc complex on static, stress view or CT radiography.
  • Associated injuries - other than the lisfranc complex - are permitted provided those injuries are not deemed to significantly influence the rehabilitation or recovery of the patient at the discretion of the enrolling surgeon
  • Adequate reduction to within 1mm of lisfranc complex at time of fixation
  • Hardware across the midfoot (tarsal-metatarsal joints 1-3)

排除标准

  • Subject has a significant pre-existing foot injury
  • Subject has a delay in initial treatment greater than 28 days from time of injury
  • Subject has an active infection in the area of surgical approach requiring surgical debridement
  • Subject has concomitant injury which, in the opinion of the attending surgeon, is likely to impair rehabilitation or prolong fracture healing time (another long bone fracture, ipsilateral limb injury)
  • Subject has a history of rheumatoid arthritis, Diabetes, fibrous dysplasia, chronic renal failure, Paget's disease, or osteopetrosis or any other pre-existing pathologic condition affecting the Lisfranc complex
  • Subject has a high risk of death from surgery (ASA physical status Class V)
  • Subject is likely unable to maintain follow-up(no fixed address, plans to move out of town in the next year, states unable to comply with protocol, etc.)
  • Subject has cognitive impairment or language difficulties that would impede the valid completion of questionnaires
  • Subject is pregnant
  • There has been loss of fixation or reduction prior to enrollment
  • Previous corrective foot surgery
  • Associated fracture of calcaneus, talus, or tibial plafond.
  • Pathologic fracture
  • Loss of fixation or reduction prior to enrollment

结局指标

主要结局

SF-36

时间窗: 2 years

Patient reported measure on physical and mental status on 36 items across eight health domains.

AOFAS - American Orthopaedic Foot and Ankle Society Midfoot Score

时间窗: 2 years

Subjective and objective evaluation of the midfoot with breakdown by function (45 points), pain (40 points), and alignment (15 points) with a yield anywhere between 0 and 100 points where 100 points is a perfect score.

VAS-FA - Visual Analog Scale Foot and Ankle

时间窗: 2 years

Patient reported responses on 20 subjective questions (Pain - 4; functional deficits -13; other complaints - 3) equally weighted. Possible score out of 100.

VAS - Visual Analogue Scale (Patient Satisfaction)

时间窗: 2 years

Single visual analogue scale to evaluate patient satisfaction on a scale of 0 to 100.

次要结局

  • Cost-effectiveness(2 years)
  • Radiologic outcome(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Paul Duffy

Division Head, Orthopaedic Trauma

University of Calgary

研究点 (3)

Loading locations...

相似试验